A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma

Jianqiang Qian(Nantong University), Yong Ling(Nantong University), Peng Zhu(Macau University of Science and Technology), Zhongyuan Xu(Nanfang Hospital), Yipeng Gu(Nantong University), Chi Meng(Ingenierie des Materiaux polymeres), Fansheng Ran(Second Military Medical University), Yun Liu(Shandong Provincial Hospital), Yanan Zhang(Dalian Medical University), Wenpei Shan(Nantong University), Ang He(Zhongyuan University of Technology)
Journal of Natural Products
November 21, 2021
10.1021/acs.jnatprod.1c00618
Cited by 28

Related Papers

The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
|Drug Design Development and Therapy|2021|377
Carbon-based quantum dots for fluorescence imaging of cells and tissues
|RSC Advances|2014|329
Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies
|Chemical Science|2024|126
Transformation, Absorption and Toxicological Mechanisms of Silver Nanoparticles in the Gastrointestinal Tract Following Oral Exposure
|ACS Nano|2023|79
Evaluation of Safety of Treatment With Anti–Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors
|JAMA Oncology|2022|69